DNA-PK is a DNA sensor for IRF-3-dependent innate immunity

被引:324
|
作者
Ferguson, Brian J. [1 ,2 ]
Mansur, Daniel S. [1 ]
Peters, Nicholas E. [1 ]
Ren, Hongwei [1 ,2 ]
Smith, Geoffrey L. [1 ,2 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Virol, London, England
[2] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
来源
ELIFE | 2012年 / 1卷
基金
英国医学研究理事会; 英国惠康基金;
关键词
DEPENDENT PROTEIN-KINASE; NEUTROPHIL EXTRACELLULAR TRAPS; INTRACELLULAR DNA; CYTOSOLIC DNA; V(D)J RECOMBINATION; AUTOIMMUNE-DISEASE; CYTOPLASMIC DNA; DAI DLM-1/ZBP1; MAMMALIAN DNA; IN-VIVO;
D O I
10.7554/eLife.00047
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Innate immunity is the first immunological defence against pathogens. During virus infection detection of nucleic acids is crucial for the inflammatory response. Here we identify DNA-dependent protein kinase (DNA-PK) as a DNA sensor that activates innate immunity. We show that DNA-PK acts as a pattern recognition receptor, binding cytoplasmic DNA and triggering the transcription of type I interferon (IFN), cytokine and chemokine genes in a manner dependent on IFN regulatory factor 3 (IRF-3), TANK-binding kinase 1 (TBK1) and stimulator of interferon genes (STING). Both cells and mice lacking DNA-PKcs show attenuated cytokine responses to both DNA and DNA viruses but not to RNA or RNA virus infection. DNA-PK has well-established functions in the DNA repair and V(D)J recombination, hence loss of DNA-PK leads to severe combined immunodeficiency (SCID). However, we now define a novel anti-microbial function for DNA-PK, a finding with implications for host defence, vaccine development and autoimmunity.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] CAS9 is a genome mutator by directly disrupting DNA-PK dependent DNA repair pathway
    Shuxiang Xu
    Jinchul Kim
    Qingshuang Tang
    Qu Chen
    Jingfeng Liu
    Yang Xu
    Xuemei Fu
    Protein & Cell, 2020, 11 (05) : 352 - 365
  • [42] Role of DNA-PK subunits in radiosensitization by hyperthermia
    Woudstra, EC
    Konings, AWT
    Jeggo, PA
    Kampinga, HH
    RADIATION RESEARCH, 1999, 152 (02) : 214 - 218
  • [43] Vanillins - a novel family of DNA-PK inhibitors
    Durant, S
    Karran, P
    NUCLEIC ACIDS RESEARCH, 2003, 31 (19) : 5501 - 5512
  • [44] DNA-PK targeting virotherapy, a promising approach
    Tsuboi, Koji
    TRANSLATIONAL CANCER RESEARCH, 2012, 1 (01) : 2 - 3
  • [45] New targets to translate DNA-PK signals
    Meek, Katheryn
    CELL CYCLE, 2009, 8 (23) : 3809 - 3809
  • [46] DNA-PK as an Emerging Therapeutic Target in Cancer
    Mohiuddin, Ismail S.
    Kang, Min H.
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [47] DNA-Dependent Protein Kinase (DNA-PK) Regulates TNF-Induced VCAM-1 Expression Independently of its Function in DNA Repair: A Novel Role of DNA-PK and its Involvement in Athrogenesis
    Ju, Jihang
    Kim, Hogyoung
    Naura, Amarjit S.
    Wilk, Anna M.
    Reiss, Krzysztof
    Strong, Jack
    Boulares, Hamid A.
    CIRCULATION, 2012, 126 (21)
  • [48] Backup pathways of NHEJ are suppressed by DNA-PK
    Perrault, R
    Wang, HC
    Wang, ML
    Rosidi, B
    Iliakis, G
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 92 (04) : 781 - 794
  • [49] Hypoxia-selective DNA-PK inhibitor
    Kyle, Alastair H.
    Baker, Jennifer H. E.
    Fryer, Karen H.
    Banadth, Judit
    Wang, Taixiang
    Porres, Soraya S.
    Mann, Sam E.
    Hynd, George
    Menear, Keith
    Minchinton, Andrew, I
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [50] The role of DNA-PK in aging and energy metabolism
    Chung, Jay H.
    FEBS JOURNAL, 2018, 285 (11) : 1959 - 1972